A review of CD19-targeted immunotherapies for relapsed or refractory acute lymphoblastic leukemia

Journal of Oncology Pharmacy Practice, Ahead of Print.


from Cancer via ola Kala on Inoreader http://ift.tt/2rcZdya
via IFTTT